Colossal uses gene editing to bring dire wolves back from extinction, marking a breakthrough in de-extinction science with the birth of Romulus and Remus.

Tom Brady’s appearance on Logan Paul’s Impaulsive podcast earlier this month revealed a more vulnerable side of the ...

Colossal's de-extinction process involved a sophisticated fusion of ancient DNA analysis, CRISPR gene editing, and ...

In a scientific achievement that reads like science fiction made real, Colossal Biosciences has accomplished what many ...

Dallas-based biotechnology company Colossal Biosciences announced the successful birth of three healthy dire wolf pups after ...

"De-extinction" takes center stage as environmentalists express dismay over erosion of the Endangered Species Act ...

Time plans to launch a new editorial vertical called Time Longevity, dedicated to the coverage of science, health, business, tech and policy innovations that address aging and the human lifespan, its ...

In this article, we are going to take a look at where Cogent Biosciences, Inc. (NASDAQ:COGT) stands against other best low priced biotech stocks to buy now. On May 8, Michael Yee, Senior Biotech ...

Since opening the $17 million RNA facility in 2021, GreenLight Biosciences has expanded its staff to more than 30 and is adding space to meet rising product demand. The company produces RNA-based crop ...

Coherus BioSciences, Inc. announced the completion of its strategic transformation to focus on innovative oncology during Q2 2025, highlighting encouraging Phase 1b data for CHS-114, an anti-CCR8 ...

Colossal Biosciences, a Texas-based biotech company, made headlines this April after falsely claiming to resurrect the extinct dire wolf. The company presents this as a breakthrough for ...

Professor Andrew Pask, Michelle Dracoulis Mayor Derwent Valley Council with Ben Lamm CEO Colossal Biosciences. Picture: Nikki Davis-Jones “This is a really recent extinction. It’s a man-made ...